+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-01-17Number of Pages: 165

Biodegradable Stents Market (Stent Type - Coronary Artery Stent and Peripheral Artery Stents; Material - Polymer Based and Metal Based; End Users - Hospitals, Cardiac Catheterization Laboratories, and Ambulatory Surgery Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Biodegradable Stents Market: Snapshot

The biodegradable stents are used for treating cardiovascular conditions pertaining to the coronary artery. These stents are also known as bioabsorbable or bioresorbable vascular scaffolds and are surgically placed in the coronary artery for eluting the drug that is administered for vascular restoration and the polymer coating. The biggest advantage of these stents is that they get entirely absorbed in the vessels over a period of time, reducing the risk of complications or infections. This advantage is the primary reason for the growth of the global biodegradable stents market. According to the research report, the global biodegradable stents market was valued at US$18 mn in 2015 and is expected to reach US$1.7 bn by 2024, as the market progresses at a CAGR of 30.1% between 2016 and 2024.

biodegradable stents market

Advantages of Biodegradable Stents Keep the Sentiment in Global Market Positive

As compared to predecessors of biodegradable stents, the newer technology has significantly reduced the risk of thrombosis, in in-stent restenosis, dual anti-platelet therapy, and second surgery for removal of the stent. These factors have played a pivotal role in shaping the trajectory of the global market in a positive direction over the past few years. The efficiency of biodegradable stents has won the market numerous consumers in the recent past. Thus, several patients and cardiologists have shown a keen interest in the uptake of biodegradable stents in the treatment of coronary and peripheral artery diseases.

The two type of stents available in the global market are the coronary artery stents and peripheral artery stents. Of these, the coronary artery stents held a dominant share in the global market in 2015. The segment is expected to continue its dominance in the coming years due to the exponentially rising number of deaths due to cardiovascular diseases. The high prevalence of coronary artery diseases across the globe around the world, rising preference of cardiologists towards percutaneous coronary intervention procedures, and increasing uptake of use of stents are expected to make a significant contribution to the soaring revenue of this segment in the forecast period.

Asia Pacific Paces Ahead due to Vast Unmet Medical Needs

In terms of geography, the global biodegradable market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Europe held a lion’s share in the global biodegradable stents market in 2015. Asia Pacific closely followed as the developing nations of the region are showing keen interest in uptake of newer technologies. These regions are expected to show continued progress in the overall market due to high adoption rate of biodegradable stents due to quick approvals from regulatory bodies. Furthermore, high incidence of diabetes and hypertension across Asia Pacific are also expected to spike the demand for biodegradable stents as patients suffering from these conditions are highly susceptible to cardiovascular diseases. The report indicates that North America biodegradable stents market will also show considerable progress with recent approvals from the U.S. FDA.

The key players operating in the global biodegradable stents market are Abbott Laboratories, Boston Scientific, Inc., Kyoto Medical Planning, Biotronik, Elixir Medical Corporation, Sahajanand Medical Technologies, and Terumo Europe NV. The competitive landscape in the global biodegradable stents market is likely to remain consolidated all throughout 2016 and 2024 as major players will hold a dominant share.

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Biodegradable Stents: Market Snapshot
3.2 Global Biodegradable Stents Market Outlook, 2015
3.3 Global Biodegradable Stents Market: Opportunity Map

Section 4 Market Overview
4.1 Product Overview
4.2 Global Biodegradable Stents Market: Key Industry Developments
4.3 Global Market Size (US$ Mn) Forecast, 2014–2024

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
      5.2.1 Rising incidences of coronary and peripheral artery diseases
      5.2.2 Growing Preference of Patients For Minimally Invasive Therapies
      5.2.3 Major Advantages over Non-degradable Drug Eluting Stents
      5.2.4 Various Regulatory Approvals in the recent past
      5.2.5 Increasing number of applications in various disease indications
5.3 Restraints
      5.3.1 Slow Adoption of of this market 
      5.3.2 High Cost of the of this market
5.4 Opportunities
      5.4.1 Drug Filled Stents – The future of Stents 
      5.4.2 Increasing applications of the biodegradable stents – Looking beyond coronary and peripheral artery treatment 
5.5 Porters Analysis

Section 6 Biodegradable Stents Market Analysis, by Stent Type  
6.1 Key Findings
6.2 Introduction
6.3 Global Biodegradable Stents Market Value Share Analysis, by Stent Type  
6.4 Market Forecast, by Stent Type  
6.5 Market Analysis, by Stent Type  
      6.5.1 Coronary Artery Stents
      6.5.2 Peripheral Artery Stents
6.6 Biodegradable Stents Market Attractiveness Analysis, by Stent Type  
6.7 Key Trends

Section 7 Biodegradable Stents Market Analysis, by Material Type  
7.1 Key Findings
7.2 Introduction
7.3 Global Biodegradable Stents Market Value Share Analysis, by Material Type  
7.4 Market Forecast, by Material Type  
7.5 Market Analysis, by Material Type  
      7.5.1 Polymer Based 
      7.5.2 Metal Based 
7.6 Biodegradable Stents Market Attractiveness Analysis, by Material Type  
7.7 Key Trends

Section 8 Biodegradable Stents Market Analysis, by End Users  
8.1 Key Findings
8.2 Introduction
8.3 Global Biodegradable Stents Market Value Share Analysis, by End Users  
8.4 Market Forecast, by End Users  
8.5 Market Analysis, by End Users  
      8.5.1 Hospitals      
      8.5.2 Cardiac Catheterization Laboratories
      8.5.3 Ambulatory Surgery Centers  
8.6 Biodegradable Stents Market Attractiveness Analysis, by End Users  

Section 9 Biodegradable Stents Market Analysis, by Region
9.1 Global Market Snapshot, by Country
9.2 Global Market Value Share Analysis, by Region
9.3 Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Biodegradable Stents Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Market Analysis, by Country
      10.3.1 North America Market Value Share Analysis, by Country
      10.3.2 North America Market Forecast by Country
10.4 Market Analysis, by Stent Type 
      10.4.1 North America Market Value Share Analysis, by Stent Type  
      10.4.2 North America Market Forecast, by Stent Type  
10.5 Market Analysis, by Material Type 
      10.5.1 North America Market Value Share Analysis, by Material Type 
      10.5.2 North America Market Forecast, by Material Type 
10.6 Market Analysis, by End Users 
      10.6.1 North America Market Value Share Analysis, by End Users  
      10.6.2 North America Market Forecast, by End Users  
10.7 North America Market Attractiveness Analysis
      10.7.1 By Stent Type 
      10.7.2 By Material Type 
      10.7.3 By End Users 
10.8 Market Trends

Section 11 Europe Biodegradable Stents Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Market Analysis, by Country
      11.3.1 Europe Market Value Share Analysis, by Country
      11.3.2 Europe Market Forecast By Country
11.4 Market Analysis, by Stent Type 
      11.4.1 Europe Market Value Share Analysis, by Stent Type  
      11.4.2 Europe Market Forecast, by Stent Type  
11.5 Market Analysis, by Material Type 
      11.5.1 Europe Market Value Share Analysis, by Material Type 
      11.5.2 Europe Market Forecast, by Material Type 
11.6 Market Analysis, by End Users 
      11.6.1 Europe Market Value Share Analysis, by End Users 
      11.6.2 Europe Market Forecast, by End Users  
11.7 Europe Market Attractiveness Analysis
      11.7.1 By Stent Type 
      11.7.2 By Material Type 
      11.7.3 By End Users 
11.8 Market Trends

Section 12 Asia Pacific Biodegradable Stents Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, by Country
      12.3.1 Asia Pacific Market Value Share Analysis, by Country
      12.3.2 Asia Pacific Market Forecast By Country
12.4 Market Analysis, by Stent Type 
      12.4.1 Asia Pacific Market Value Share Analysis, by Stent Type  
      12.4.2 Asia Pacific Market Forecast, by Stent Type  
12.5 Market Analysis, by Material Type 
      12.5.1 Asia Pacific Market Value Share Analysis, by Material Type 
      12.5.2 Asia Pacific Market Forecast, by Material Type 
12.6 Market Analysis, by End Users 
      12.6.1 Asia Pacific Market Value Share Analysis, by End Users 
      12.6.2 Asia Pacific Market Forecast, by End Users  
12.7 Asia Pacific Market Attractiveness Analysis
      12.7.1 By Stent Type 
      12.7.2 By Material Type 
      12.7.3 By End Users 
12.8 Market Trends

Section 13 Latin America Biodegradable Stents Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Market Analysis, by Country
      13.3.1 Latin America Market Value Share Analysis, by Country
      13.3.2 Latin America Market Forecast By Country
13.4 Market Analysis, by Stent Type 
      13.4.1 Latin America Market Value Share Analysis, by Stent Type  
      13.4.2 Latin America Market Forecast, by Stent Type  
13.5 Market Analysis, by Material Type 
      13.5.1 Latin America Market Value Share Analysis, by Material Type 
      13.5.2 Latin America Market Forecast, by Material Type 
13.6 Market Analysis, by End Users 
      13.6.1 Latin America Market Value Share Analysis, by End Users 
      13.6.2 Latin America Market Forecast, by End Users  
13.7 Latin America Market Attractiveness Analysis
      13.7.1 By Stent Type 
      13.7.2 By Material Type 
      13.7.3 By End Users 
13.8 Market Trends

Section 14 MEA Biodegradable Stents Market Analysis
14.1 Key Findings
14.2 Market Overview
14.3 Market Analysis, by Country
      14.3.1 MEA Market Value Share Analysis, by Country
      14.3.2 MEA Market Forecast By Country
14.4 Market Analysis, by Stent Type 
      14.4.1 MEA Market Value Share Analysis, by Stent Type  
      14.4.2 MEA Market Forecast, by Stent Type  
14.5 Market Analysis, by Material Type 
      14.5.1 MEA Market Value Share Analysis, by Material Type 
      14.5.2 MEA Market Forecast, by Material Type 
14.6 Market Analysis, by End Users 
      14.6.1 MEA Market Value Share Analysis, by End Users 
      14.6.2 MEA Market Forecast, by End Users  
14.7 MEA Market Attractiveness Analysis
      14.7.1 By Stent Type 
      14.7.2 By Material Type 
      14.7.3 By End Users 
14.8 Market Trends

Section 15 Company Profiles
15.1 Global Biodegradable Stents Market Share Analysis, by Company (2015)
15.2 Competition Matrix
15.3 Company Profiles
      15.3.1 Abbott Laboratories
               15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.1.2 Financial Overview
               15.3.1.3 Product Portfolio
               15.3.1.4 SWOT Analysis
               15.3.1.5 Strategic Overview
      15.3.2 Boston Scientific, Inc.
               15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.2.2 Financial Overview
               15.3.2.3 Product Portfolio
               15.3.2.4 SWOT Analysis
               15.3.2.5 Strategic Overview
      15.3.3 Biotronik
               15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.3.2 Financial Overview
               15.3.3.3 Product Portfolio
               15.3.3.4 SWOT Analysis
               15.3.3.5 Strategic Overview
      15.3.4 Kyoto Medical Corporation 
               15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.4.2 Financial Overview
               15.3.4.3 Product Portfolio
               15.3.4.4 SWOT Analysis
               15.3.4.5 Strategic Overview
      15.3.5 Elixir Medical Corporation
               15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.5.2 Financial Overview
               15.3.5.3 Product Portfolio
               15.3.5.4 SWOT Analysis
               15.3.5.5 Strategic Overview
      15.3.6 Biosensors International
               15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.6.2 Financial Overview
               15.3.6.3 Product Portfolio
               15.3.6.4 SWOT Analysis
               15.3.6.5 Strategic Overview
      15.3.7 Terumo Europe NV
               15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.7.2 Financial Overview
               15.3.7.3 Product Portfolio
               15.3.7.4 SWOT Analysis
               15.3.7.5 Strategic Overview
      15.3.8 Ella CS
               15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.8.2 Financial Overview
               15.3.8.3 Product Portfolio
               15.3.8.4 SWOT Analysis
               15.3.8.5 Strategic Overview
      15.3.9 Sahajanand Medical Technologies
               15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
               15.3.9.2 Financial Overview
               15.3.9.3 Product Portfolio
               15.3.9.4 SWOT Analysis
               15.3.9.5 Strategic Overview
      15.3.10 Others

List of Figures

Figure 01: Global Biodegradable Stents Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Global Biodegradable Stents Market Value Share Analysis, by Stent Type, 2016 and 2024
Figure 03: Global Coronary Artery Stent Market Revenue (US$ Mn), 2014–2024
Figure 04: Global Peripheral Artery Stent Market Revenue (US$ Mn), 2014–2024
Figure 05: Biodegradable Stents Market Attractiveness Analysis, by Stent Type, 2016–2024
Figure 06: Global Biodegradable Stents Market Value Share Analysis, by Material Type, 2016 and 2024
Figure 07: Global Polymer Based Stent Market Revenue (US$ Mn), 2014–2024
Figure 08: Global Metal Based Stent Market Revenue (US$ Mn), 2014–2024
Figure 09: Biodegradable Stents Market Attractiveness Analysis, by Material Stent Type, 2016–2024 
Figure 10: Global Biodegradable Stents Market Value Share Analysis, by End Users, 2016 and 2024
Figure 11: Global Hospitals Market Revenue (US$ Mn), 2014–2024
Figure 12: Global Cardiac Catheterization Laboratories Market Revenue (US$ Mn), 2014–2024
Figure 13: Global Ambulatory Surgery Centers Market Revenue (US$ Mn), 2014–2024
Figure 14: Biodegradable Stents Market Attractiveness Analysis, by End Users, 2016–2024
Figure 15: Global Biodegradable Stents Market Value Share Analysis, by Region, 2016 and 2024
Figure 16: Global Biodegradable Stents Market Attractiveness Analysis, by Region, 2016–2024
Figure 17: North America Biodegradable Stents Market Size (US$ Mn) Forecast, 2014–2024
Figure 18: North America Market Attractiveness Analysis, by Country, 2016–2024
Figure 19: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 20: North America Market Value Share Analysis, by Stent Type, 2016 and 2024
Figure 21: North America Biodegradable Stents Market Value Share Analysis by Material Type, 2016 and 2024
Figure 22: North America Market Value Share Analysis, by End Users, 2016 and 2024
Figure 23: North America Market Attractiveness Analysis, by Stent Type, 2016-2024
Figure 24: North America Biodegradable Stents Market Attractiveness Analysis, by Material Type, 2016-2024
Figure 25: North America Market Attractiveness Analysis, by End Users, 2016-2024
Figure 26: Europe Biodegradable Stents Market Size (US$ Mn) Forecast, 2014–2024
Figure 27: Europe Market Attractiveness Analysis, by Country/ Region, 2016–2024
Figure 28: Europe Biodegradable Stents Market Value Share Analysis, by Country/Region, 2016 and 2024
Figure 29: Europe Market Value Share Analysis, by Stent Type, 2016 and 2024
Figure 30: Europe Biodegradable Stents Market Value Share Analysis, by Material Type, 2016 and 2024
Figure 31: Europe Market Value Share Analysis, by End Users, 2016 and 2024
Figure 32: Europe Biodegradable Stents Market Attractiveness Analysis, by Stent Type, 2016–2024
Figure 33: Europe Biodegradable Stents Market Attractiveness Analysis, by Material Type, 2016–2024
Figure 34: Europe Market Attractiveness Analysis, by End Users, 2016–2024
Figure 35: Asia Pacific Biodegradable Stents Market Size (US$ Mn) Forecast, 2014–2024
Figure 36: Asia PacificMarket Attractiveness Analysis, by Country/Region, 2016–2024
Figure 37: Asia Pacific Biodegradable Stents Market Value Share Analysis, by Country/ Region, 2016 and 2024
Figure 38: Asia Pacific Biodegradable Stents Market Value Share Analysis, by Stent Type, 2016 and 2024
Figure 39: Asia Pacific Market Value Share Analysis, by Material Stent Type, 2016 and 2024
Figure 40: Asia Pacific Biodegradable Stents Market Value Share Analysis, by End Users, 2016 and 2024
Figure 41: Asia Pacific Market Attractiveness Analysis, by Stent Type, 2016–2024
Figure 42: Asia Pacific Biodegradable Stents Market Attractiveness Analysis, by Material Type, 2016–2024
Figure 43: Asia Pacific Market Attractiveness Analysis, by End Users, 2016–2024
Figure 44: Latin America Biodegradable Stents Market Size (US$ Mn) Forecast, 2014–2024
Figure 45: Latin America Biodegradable Stents Market Attractiveness Analysis, by Country/Region, 2016–2024
Figure 46: Latin America Biodegradable Stents Market Value Share Analysis, by Country/Region, 2016 and 2024
Figure 47: Latin America Market Value Share Analysis, by Stent Type, 2016 and 2024
Figure 48: Latin America Market Value Share Analysis, by Material Type, 2016 and 2024
Figure 49: Latin America Biodegradable Stents Market Value Share Analysis, by End Users, 2016 and 2024
Figure 50: Latin America Market Attractiveness Analysis, by Stent Type, 2016–2024
Figure 51: Latin America Market Attractiveness Analysis, by Material Type, 2016–2024
Figure 52: Latin America Biodegradable Stents Market Attractiveness Analysis, by End Users, 2016–2024
Figure 53: MEA Biodegradable Stents Market Size (US$ Mn) Forecast, 2014–2024
Figure 54: MEA Market Attractiveness Analysis, by Country/ Region, 2016-2024
Figure 55: MEA Market Value Share Analysis, by Country/Region, 2016 and 2024
Figure 56: MEA Biodegradable Stents Market Value Share Analysis, by Stent Type, 2016 and 2024
Figure 57: MEA Market Value Share Analysis, by Material Type, 2016 and 2024
Figure 58: MEA Biodegradable Stents Market Value Share Analysis, by End Users, 2016 and 2024
Figure 59: MEA Market Attractiveness Analysis, by Stent Type, 2016–2024
Figure 60: MEA Market Attractiveness Analysis, by Material Stent Type, 2016-2024
Figure 61: MEA Biodegradable Stents Market Attractiveness Analysis, by End Users, 2016-2024
Figure 62: Global Biodegradable Stents Market Share Analysis, by Company, (2015)

List of Tables

Table 01: Global Biodegradable Stents Market Size (US$ Mn) Forecast, by Stent Type, 2014–2024
Table 02: Global Biodegradable Stents Market Size (US$ Mn) Forecast, by Material Type, 2014–2024
Table 03: Global Biodegradable Stents Market Size (US$ Mn) Forecast, by End Users, 2014–2024
Table 04: Global Biodegradable Stents Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Biodegradable Stents Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 06: North America Biodegradable Stents Market Size (US$ Mn) Forecast, by Stent Type, 2014–2024
Table 07: North America Biodegradable Stents Market Size (US$ Mn) Forecast, by Material Type, 2014–2024
Table 08: North America Market Size (US$ Mn) Forecast, by End Users, 2014–2024
Table 09: Europe Biodegradable Stents Market Size (US$ Mn) Forecast, by Country/Region, 2014–2024
Table 10: Europe Biodegradable Stents Market Size (US$ Mn) Forecast, by Stent Type, 2014–2024
Table 11: Europe Biodegradable Stents Market Size (US$ Mn) Forecast, by Material Stent Type, 2014–2024
Table 12: Europe Biodegradable Stents Market Size (US$ Mn) Forecast, by End Users, 2014–2024
Table 13: Asia Pacific Biodegradable Stents Market Size (US$ Mn) Forecast, by Country/ Region, 2014–2024
Table 14: Asia Pacific Biodegradable Stents Market Size (US$ Mn) Forecast, by Stent Type, 2014–2024
Table 15: Asia Pacific Biodegradable Stents Market Size (US$ Mn) Forecast, by Material Stent Type, 2014–2024
Table 16: Asia Pacific Biodegradable Stents Market Size (US$ Mn) Forecast, by End Users, 2014–2024
Table 17: Latin America Biodegradable Stents Market Size (US$ Mn) Forecast, by Country/Region, 2014–2024
Table 18: Latin America Biodegradable Stents Market Size (US$ Mn) Forecast, by Stent Type, 2014–2024
Table 19: Latin America Biodegradable Stents Market Size (US$ Mn) Forecast, by Material Type, 2014–2024
Table 20: Latin America Biodegradable Stents Market Size (US$ Mn) Forecast, by End Users, 2014–2024
Table 21: MEA Biodegradable Stents Market Size (US$ Mn) Forecast, by Country/ Region, 2014–2024
Table 22: MEA Biodegradable Stents Market Size (US$ Mn) Forecast, by Stent Type, 2014–2024
Table 23: MEA Biodegradable Stents Market Size (US$ Mn) Forecast, by Material Stent Type, 2014–2024
Table 24: MEA Biodegradable Stents Market Size (US$ Mn) Forecast, by End Users, 2014–2024

Global Biodegradable Stents Market: Overview

Biodegradable Stents are the third generation of stents used in the treatment of coronary artery diseases, which are completely absorbed in the body after the drug is eluted. The biodegradable stents have emerged as a perfect replacement to the standard Drug Eluting Stents having a permanent polymer coating over them. Introduction of biodegradable stents has resulted into reduction in rates of thrombosis, in-stent restenosis, and dual anti-platelet therapy required with the DES and Bare Metal Stents, as the polymer or metal is completely absorbed in the vessel, resulting into efficient drug delivery, and vascular restoration.  Players in the stents market are now looking beyond the coronary and peripheral artery disease treatment applications of the biodegradable stents after various clinical trials which have demonstrated the efficiency of these biodegradable stents in other vascular interventions.

Global Biodegradable Stents Market: Scope

The market overview section of the report comprises qualitative analysis of the overall biodegradable stents market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, market opportunity analysis for the stent type, and material types, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics.

Global Biodegradable Stents Market: Segmentation

The global biodegradable stents market has been segmented on the basis of stent type, material and end users. On the basis of stent type, the global market is categorized as coronary artery stent, and peripheral artery stent. Moreover, on the basis of material, the biodegradable stents market has been segmented into polymer based, and metal based stent. Furthermore, on the basis of end users, the global biodegradable stents market has been classified as hospitals, cardiac catheterization laboratories, and ambulatory surgery centers.

The market for these stent types, material and end users has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.

Global Biodegradable Stents Market: Regional Outlook

Geographically, the biodegradable stents market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of types, material and applications, along with the CAGR (%) for the forecast period 2016 to 2024.

Key Players Mentioned in this Report are:

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global biodegradable stents market, in terms of percentage share in 2016 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

The report concludes with the profiles of major players in the global biodegradable stents market such as Abbott Laboratories, Boston Scientific, Inc., Terumo Europe NV, Biotronik, Elixir Medical Corporation, Sahajanand Medical technologies, and Kyoto Medical Planning among others.  The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global Biodegradable Stents Market is segmented as follows:

  • Global Biodegradable Stents Market, by Stent Type
    • Coronary Artery Stents
    • Peripheral Artery Stents
       
  • Global Biodegradable Stents Market, by Material
    • Polymer Based
    • Metal Based
       
  • Global Biodegradable Stents Market, by End user
    • Hospitals
    • Cardiac Catheterization Laboratories
    • Ambulatory Surgery Centers
       
  • Global Biodegradable Stents Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa


 
 
Back To Top